Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)

Clinical trial NCT00440427 · COMPLETED

Trial details

NCT number: NCT00440427
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2007-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.